These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26111356)

  • 1. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.
    Olivares JM; Álvarez E; Carrasco JL; Pérez Páramo M; López-Gómez V
    Int Clin Psychopharmacol; 2015 Sep; 30(5):265-71. PubMed ID: 26111356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.
    Karaiskos D; Pappa D; Tzavellas E; Siarkos K; Katirtzoglou E; Papadimitriou GN; Politis A
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
    Ruiz MA; Álvarez E; Carrasco JL; Olivares JM; Pérez M; Rejas J
    Drug Des Devel Ther; 2015; 9():4329-40. PubMed ID: 26273194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.
    Arnold LM; Sarzi-Puttini P; Arsenault P; Khan T; Bhadra Brown P; Clair A; Scavone JM; Driscoll J; Landen J; Pauer L
    J Rheumatol; 2015 Jul; 42(7):1237-44. PubMed ID: 26034150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety associated with comorbid depression.
    Möller HJ
    J Clin Psychiatry; 2002; 63 Suppl 14():22-6. PubMed ID: 12562115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label trial of risperidone augmentation for refractory anxiety disorders.
    Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH
    J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
    Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
    Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
    Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
    Montgomery SA; Herman BK; Schweizer E; Mandel FS
    Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study.
    Pae CU; Marks DM; Han C; Masand PS; Patkar AA
    Int Clin Psychopharmacol; 2009 Jan; 24(1):29-33. PubMed ID: 19060720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.
    Carta MG; Tondo L; Balestrieri M; Caraci F; Dell'osso L; Di Sciascio G; Faravelli C; Hardoy MC; Lecca ME; Moro MF; Bhat KM; Casacchia M; Drago F
    BMC Psychiatry; 2011 Oct; 11():164. PubMed ID: 21985128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.
    Fountoulakis KN; Karavelas V; Moysidou S; Mavridis D; Pastiadis K; Petalidou N; Nimatoudis I; Kasper S
    Pharmacopsychiatry; 2019 Jul; 52(4):193-202. PubMed ID: 30170329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
    Ball S; Marangell LB; Lipsius S; Russell JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():217-21. PubMed ID: 23313564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.